Meeting Date
September 5, 2007
Meeting Location
Natcher Conference Center
NIH Campus, Bldg. 45
Bethesda, MD
Meeting Objectives:
For Phase III Prevention Trials
- Efficiency
- Validated biomarkers of risk and risk reduction
- Pharmacogenomics
For Breast Cancer Studies
- Prediction of response to endocrine interventions
- ER -negative breast cancer
- Options for pre-menopausal women
